In the entire patient cohort, the patients with clinically significant cancer had older age, a higher rate of DRE abnormalities, higher serum PSA levels, and lower serum testosterone levels than those with clinically insignificant cancer or benign disease. Here, KLK3 is linked to neoplasm.